Preclinical evaluation of zinc phthalocyanine tetrasulfonate-based PDT

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 5686, Issue , 2005, Pages 624-630

  Borgatti Jeffreys, Antonella ^a   Hooser, Stephen B ^a   Miller, Margaret A ^a   Thomas, Rose M ^b   DeGortari, Amalia ^a   Lucroy, Michael D ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Purdue University   (United States)

Author keywords

Animal model; Canine; Clinical trial; Dog; Photodynamic therapy; Second generation photosensitizer

Indexed keywords

ANIMAL MODEL; CANINE; CLINICAL TRIAL; DOG; SECOND-GENERATION PHOTOSENSITIZER;

MEDICAL IMAGING; ONCOLOGY; PHOTOSENSITIZERS; RADIOTHERAPY; TOXICITY; TUMORS; ZINC COMPOUNDS;

PHOTODYNAMIC THERAPY;

EID: 23244438359     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.588378     Document Type: Conference Paper

References (26)

1. Brown SB, Brown EA, Walker I. "The present and future role of photodynamic therapy in cancer treatment." Lancet Oncol 5:497-508, 2004.
2. Jacobs TM, Rosen GM. "Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog." J Am Anim Hosp Assoc 36:257-261, 2000.
3. Lucroy MD. "Photodynamic therapy for companion animals with cancer." Vet Clin North Am Small Anim Pract 32:693-702, 2002.
4. Lucroy MD, Edwards BF, Madewell BR. "Veterinary photodynamic therapy." J Am Vet Med Assoc 216:1745-1751, 2000.
5. Lucroy MD, Magne ML, Peavy GM, et al. "Photodynamic therapy in veterinary medicine: current status and implications for applications in human disease." J Clin Laser Med Surg 14:305-310, 1996.
6. Magne ML, Rodriguez CO, Autry SA, et al. "Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer." Lasers Surg Med 20:202-209, 1997.
7. McCaw DL, Pope ER, Payne JT, et al. "Treatment of canine oral squamous cell carcinomas with photodynamic therapy." Br J Cancer 82:1297-1299, 2000.
8. Peaston AE, Leach MW, Higgins RJ. "Photodynamic therapy for nasal and aural squamous cell carcinoma in cats." J Am Vet Med Assoc 202:1261-1265, 1993.
9. Lucroy MD, Ridgway TD, Peavy GM, et al. "Preclinical evaluation of 5-aminolevulinic acid-based photodynamic therapy for canine transitional cell carcinoma." Vet Comp Oncol 1:76-85, 2003.
10. Lucroy MD, Edwards BF, Peavy GM, et al. "Preclinical study in cats of the pro-photosensitizer 5-aminolevulinic acid." Am J Vet Res 60:1364-1370, 1999.
11. Hahn KA, Panjehpour M, Legendre AM. "Photodynamic therapy response in cats with cutaneous squamous cell carcinoma as a function of fluence." Vet Dermatol 9:3-7, 1998.
12. Leach MW, Peaston AE. "Adverse drug reaction attributable to aluminum phthalocyanine tetrasulphonate administration in domestic cats." Vet Pathol 31:283-287; 1994.
13. McCaw DL, Payne JT, Pope ER, et al. "Treatment of canine hemangiopericytomas with photodynamic therapy." Lasers Surg Med 29:23-26, 2001.
14. Lucroy MD, Long KR, Blaik MA, et al. "Photodynamic therapy for the treatment of intranasal tumors in 3 dogs and 1 cat." J Vet Intern Med 17:727-729, 2003.
15. Fingar VH, Wieman TJ, Karavolos PS, et al. "The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response." Photochem Photobiol 58:251-258, 1993.
16. Mosa M, Zitko M, Pouckova P. "Distribution and photodynamic effect of zinc phthalocyanine disulfonate in nude mice bearing mammary carcinoma." Neoplasma 44:178-183, 1997.
17. Rosenthal I, Murali Krishna C, Riesz P, et al. "The role of molecular oxygen in the photodynamic effect of phthalocyanines." Radiat Res 107:136-142, 1986.
18. Shopova M, Mantareva V, Krastev K, et al. "Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma." J Photochem Photobiol B 16:83-89, 1992.
19. You Y, Gibson SL, Hilf R, et al. "Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives." J Med Chem 46:3734-3747, 2003.
20. Minnock A, Vernon DI, Schofield J, et al. "Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria." J Photochem Photobiol B 32:159-164, 1996.
21. Beeby A, FitzGerald S, Stanley CF. "Protonation of tetrasulfonated zinc phthalocyanine in aqueous acetonitrile solution." Photochem Photobiol 74:566-569,2001.
22. Fabris C, Valduga G, Miotto G, et al. "Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis." Cancer Res 61:7495-7500, 2001.
23. Simon R, Freidlin B, Rubinstein L, et al. "Accelerated titration designs for phase I clinical trials in oncology." J Natl Cancer Inst 89:1138-1147, 1997.
24. Gorlin RJ, Peterson WC, Jr. "Oral disease in man and animals based on analysis of 1,135 cases in a variety of species." Arch Dermatol 96:390-403, 1967.
25. MacEwen EG. "Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment." Cancer Metastasis Rev 9:125-136, 1990.
26. Gardner DG. "Spontaneous squamous cell carcinomas of the oral region in domestic animals: a review and consideration of their relevance to human research." Oral Dis 2:148-154, 1996.